The closing price of Acutus Medical Inc (NASDAQ: AFIB) was $0.18 for the day, down -1.72% from the previous closing price of $0.18. In other words, the price has decreased by -$0.0031 from its previous closing price. On the day, 588025 shares were traded. AFIB stock price reached its highest trading level at $0.1810 during the session, while it also had its lowest trading level at $0.1750.
Ratios:
Our analysis of AFIB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 4.92. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.21.
On October 22, 2021, Goldman started tracking the stock assigning a Neutral rating and target price of $10.
Canaccord Genuity Upgraded its Hold to Buy on July 15, 2021, whereas the target price for the stock was revised from $11 to $18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AFIB now has a Market Capitalization of 5.18M and an Enterprise Value of 5.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.16. Its current Enterprise Value per Revenue stands at 0.29 whereas that against EBITDA is -0.26.
Stock Price History:
Over the past 52 weeks, AFIB has reached a high of $1.09, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is 0.2002, while the 200-Day Moving Average is calculated to be 0.4160.
Shares Statistics:
AFIB traded an average of 2.32M shares per day over the past three months and 493.18k shares per day over the past ten days. A total of 29.31M shares are outstanding, with a floating share count of 18.67M. Insiders hold about 36.27% of the company’s shares, while institutions hold 5.76% stake in the company. Shares short for AFIB as of Mar 15, 2024 were 984.7k with a Short Ratio of 0.43, compared to 1.15M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.36% and a Short% of Float of 3.43%.
Earnings Estimates
The firm’s stock currently is rated by 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0.41. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $6.63M to a low estimate of $6.63M. As of the current estimate, Acutus Medical Inc’s year-ago sales were $4.96M, an estimated increase of 33.60% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $6.81M, an increase of 63.30% over than the figure of $33.60% in the same quarter last year. There is a high estimate of $6.81M for the next quarter, whereas the lowest estimate is $6.81M.
A total of 1 analysts have provided revenue estimates for AFIB’s current fiscal year. The highest revenue estimate was $20.8M, while the lowest revenue estimate was $20.8M, resulting in an average revenue estimate of $20.8M. In the same quarter a year ago, actual revenue was $16.36M, up 27.10% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $35.36M in the next fiscal year. The high estimate is $35.36M and the low estimate is $35.36M. The average revenue growth estimate for next year is up 70.00% from the average revenue estimate for this year.
